FDA ANDA · ANDA202793

AZITHROMYCIN

Sponsor: NOVEL LABS INC

APPLICATION

ANDA202793

TYPE

ANDA

ROUTE

ORAL

DOSAGE FORM

FOR SUSPENSION

MARKETING STATUS

None (Tentative Approval)

Products

AZITHROMYCINNone (Tentative Approval)

AZITHROMYCIN EQ 100MG BASE/5ML · FOR SUSPENSION · ORAL

AZITHROMYCINNone (Tentative Approval)

AZITHROMYCIN EQ 200MG BASE/5ML · FOR SUSPENSION · ORAL

2016-08-26UNKNOWN · OriginalTA

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.